RxSight, Inc. Analyst EPS Estimates
Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 2 | -$0.29 | -$0.29 | -$0.29 |
Q2 2024 | 3 | -$0.22 | -$0.22 | -$0.22 |
Q3 2024 | 5 | -$0.34 | -$0.18 | -$0.25 |
Q4 2024 | 3 | -$0.19 | -$0.19 | -$0.19 |
Q1 2025 | 4 | -$0.15 | -$0.15 | -$0.15 |
Q2 2025 | 4 | -$0.10 | -$0.10 | -$0.10 |
Q3 2025 | 4 | -$0.11 | -$0.11 | -$0.11 |
Q4 2025 | 4 | -$0.02 | -$0.02 | -$0.02 |
RxSight, Inc. Earnings Date And Information
RxSight, Inc. last posted its earnings results on Monday, August 5th, 2024. The company reported $-0.16 earnings per share for the quarter, topping analysts' consensus estimates of $-0.22 by $0.06. The company had revenue of 34.89 M for the quarter and had revenue of 89.08 M for the year. RxSight, Inc. has generated $-1 earnings per share over the last year ($-1.41 diluted earnings per share) and currently has a price-to-earnings ratio of -54.1. RxSight, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, November 6th, 2024 based on prior year's report dates.
RxSight, Inc. Earnings History by Quarter
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
08/05/2024 | Q2 2024 | -$0.22 | -$0.16 | 0.06 | $32.33 M | $34.89 M |
05/06/2024 | Q1 2024 | -$0.17 | -$0.25 | -0.08 | $29.51 M | |
12/29/2023 | Q4 2023 | -$0.26 | $28.58 M | |||
11/09/2023 | Q3 2023 | -$0.42 | -$0.35 | 0.07 | $20.55 M | $30.67 M |
08/07/2023 | Q2 2023 | -$0.47 | -$0.40 | 0.07 | $19.23 M | $20.81 M |
05/09/2023 | Q1 2023 | -$0.52 | -$0.47 | 0.05 | $17.49 M | |
03/06/2023 | Q4 2022 | -$0.72 | -$0.56 | 0.16 | $16.09 M | |
11/07/2022 | Q3 2022 | -$0.70 | -$0.61 | 0.09 | $10.98 M | $12.62 M |
08/08/2022 | Q2 2022 | -$0.68 | -$0.61 | 0.07 | $10.55 M | $11.36 M |
05/05/2022 | Q1 2022 | -$0.56 | -$0.64 | -0.08 | $8.94 M | |
03/08/2022 | Q4 2021 | -$0.58 | -$0.58 | 0 | $8.43 M | |
11/10/2021 | Q3 2021 | -$0.61 | -$0.68 | -0.07 | $5.22 M | $5.79 M |
09/09/2021 | Q2 2021 | -$0.68 | -$0.51 | 0.17 | $4.92 M | $4.90 M |
03/30/2021 | Q1 2021 | -$0.36 | $3.48 M | |||
12/30/2020 | Q4 2020 | $1.38 | $4.91 M | |||
09/29/2020 | Q3 2020 | $0.31 | $4.17 M | |||
06/30/2020 | Q2 2020 | -$0.68 | $2.71 M | |||
03/30/2020 | Q1 2020 | -$0.87 | $2.89 M |
RxSight, Inc. Earnings: Frequently Asked Questions
-
When is RxSight, Inc.'s earnings date?
RxSight, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, November 6th, 2024 based off last year's report dates.
-
Did RxSight, Inc. beat their earnings estimates last quarter?
In the previous quarter, RxSight, Inc. (:RXST) reported $-0.16 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.22 by $0.06.
-
How can I listen to RxSight, Inc.'s earnings conference call?
The conference call for RxSight, Inc.'s latest earnings report can be listened to online.
-
How can I read RxSight, Inc.'s conference call transcript?
The conference call transcript for RxSight, Inc.'s latest earnings report can be read online.
-
How much revenue does RxSight, Inc. generate each year?
RxSight, Inc. (:RXST) has a recorded annual revenue of $89.08 M.
-
How much profit does RxSight, Inc. generate each year?
RxSight, Inc. (:RXST) has a recorded net income of $89.08 M. RxSight, Inc. has generated $-1.41 earnings per share over the last four quarters.
-
What is RxSight, Inc.'s price-to-earnings ratio?
RxSight, Inc. (:RXST) has a price-to-earnings ratio of -54.1 and price/earnings-to-growth ratio is -2.84.